Mesa Laboratories
MLAB
81 hedge funds and large institutions have $278M invested in Mesa Laboratories in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 5 closing their positions.
200% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
68% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 19
24% more capital invested
Capital invested by funds: $224M → $278M (+$54M)
13% more funds holding
Funds holding: 72 → 81 (+9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.14M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
+$2.93M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$969K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$958K |
| 5 |
BG
Bahl & Gaynor
Cincinnati,
Ohio
|
+$560K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$9.76M |
| 2 |
Renaissance Technologies
New York
|
-$3.75M |
| 3 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$2.41M |
| 4 |
Bank of New York Mellon
New York
|
-$1.95M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$893K |
MLAB Hedge Fund Activity: Q2 2016 in Review
81 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q2 2016, worth a combined $278M — up 24% from $224M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new MLAB positions and 5 closed out — a net gain of 10 holders — while 32 added to existing stakes and 19 trimmed.
The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $7.14M. The largest seller was Conestoga Capital Advisors, cutting an estimated $9.76M.
- 81 institutional investors held Mesa Laboratories (MLAB) as of Q2 2016, up from 72 in Q1 2016.
- Funds reported $278M of Mesa Laboratories stock for Q2 2016, up 24% quarter-over-quarter.
- 15 funds opened new Mesa Laboratories positions in Q2 2016 and 5 closed out, a net change of +10 holders.
- The largest Mesa Laboratories buyer in Q2 2016 was T. Rowe Price Associates, an estimated $7.14M added.
- The largest Mesa Laboratories seller in Q2 2016 was Conestoga Capital Advisors, an estimated $9.76M sold.
Based on aggregated 13F filings for Q2 2016.